Locations
Cambridge, MA, USA · Waltham, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2017
Nocion Therapeutics is a biopharmaceutical company focused on developing innovative therapies called nocions, which selectively target inflamed nociceptors to provide effective relief for conditions such as chronic cough, pain, and inflammation. Their unique approach involves ionizing and optimizing sodium channel blockers to create a targeted treatment that minimizes side effects and enhances efficacy compared to traditional anesthetics. With a robust pipeline addressing multiple indications across various therapeutic areas, Nocion is positioned to meet significant unmet medical needs in the market, particularly in pulmonology and pain management.
Something looks off?